drugset / Trial / NCT03282929

Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD)

NCT03282929

Phase 1 Completed 43 enrolled Bausch & Lomb Incorporated
RandomizedCrossoverOpen-labelTreatment

Summary

A single dose, open label, randomized cross-over study to explore the pharmacokinetics and pharmacodynamics of epinephrine in healthy male and female subjects

Timeline

Start
2017-03-23
Primary completion
2018-09-28
Completion
2018-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified 500 ug

Indications